Yale University School of Medicine Pediatrics Professor | |
QualificationsM.D., Boston Children's Hospital, 1954. A.B., Boston Children's Hospital, 1951. Fellowship, Boston Children's Hospital. Expertise and Research InterestsClinical features of the genetically determined anemias - sickle cell anemia and thalassemia - are being studied in a longitudinal manner. Possible new treatments of these disorders directed at stimulating production of HbF are being investigated.Perturbation of splenic function in sickle cell disease and other states using Normosky optical examination of circulating RBC is an ongoing study.Finally, studies of the History of American Pediatrics is a continuing interest. Other ExpertiseI wish to be contacted by interested students (medical, graduate or undergraduates) as a potential research mentor/thesis advisor. KeywordsCOS Keywords:Pediatrics, Sickle Cell Anemia.Additional Terms:History of Pediatrics, Sickle Cell Anemia, Spleen, Thalassemia.Publications- Pearson H A, The ever-changing content of Pediatrics over fifty years., Pediatrics, 102(1 Pt 2), 168-76, July 1998
 - Pearson H A, History of the Department of Pediatrics Yale University School of Medicine., Yale Journal of Biology and Medicine, 70(3), 201-9, May 1997
 - Pearson H A, Prevention of pneumococcal disease in sickle cell anemia [editorial; comment], Journal of Pediatrics, 129(6), 788-9, December 1996
 - Pearson H A, Cohen A R, Giardina P J, Kazazian H H, The changing profile of homozygous beta-thalassemia: demography, ethnicity, and age distribution of current North American patients and changes in two decades., Pediatrics, 97(3), 352-6, March 1996
 - Pearson H A, Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality., Advances In Pediatrics, 43, 309-34, 1996
 - Pearson H A, The American Pediatric Society., Pediatrics, 95(1), 147-51, January 1995
 - Collins A F, Pearson H A, Giardina P, McDonagh K T, Brusilow S W, Dover G J, Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial., Blood, 85(1), 43-9, 1 Jan 1995
 - Hajjar F M, Pearson H A, Pharmacologic treatment of thalassemia intermedia with hydroxyurea., Journal of Pediatrics, 125(3), 490-2, September 1994
 - Pearson H A, Pediatrics., Jama, 271(21), 1701-3, 1 Jun 1994
 - Pearson H A, Rink L, Guiliotis D K, Thalassemia major in Connecticut: a 20-year study of changing age distribution and survival., Connecticut Medicine, 58(5), 259-60, May 1994
 - Pearson H A, Stockman J A, Problems in primary care [letter; comment], New England Journal of Medicine, 329(10), 730-1, 2 Sep 1993
 - Jones T W, Boulware S D, Caprio S, Merkel P, Amiel S A, Pearson H A, Sherwin R S, Tamborlane W V, Correction of hyperinsulinemia by glyburide treatment in nondiabetic patients with thalassemia major., Pediatric Research, 33(5), 497-500, May 1993
 - Ehrenkranz R A, Gettner P A, Nelli C M, Sherwonit E A, Williams J E, Pearson H A, Ting B T, Janghorbani M, Iron absorption and incorporation into red blood cells by very low birth weight infants: studies with the stable isotope 58Fe., Journal of Pediatric Gastroenterology and Nutrition, 15(3), 270-8, October 1992
 - Pearson H A, Unforgettable patients., Journal of Pediatrics, 121(1), 154-5, July 1992
 - Pearson H A, Neonatal testing for hemoglobinopathies., Seminars In Perinatology, 15(3 Suppl 2), 9-14, June 1991
 - Pearson H A, Anemia in the newborn: a diagnostic approach and challenge., Seminars In Perinatology, 15(3 Suppl 2), 2-8, June 1991
 - Pearson H A, Centennial history of the APS., Pediatric Research, 27(6 Suppl), S4-7, June 1990
 - Pearson H A, Neonatal testing for sickle cell diseases--a historical and personal review., Pediatrics, 83(5 Pt 2), 815-8, May 1989

Profile DetailsIndividual Expertise profile of Howard A. Pearson, Copyright Howard A. Pearson. © COS Expertise TM, 2009, ProQuest LLC All rights reserved. |